Lethal to Tumors. Gentle to Life.

Next-Generation Selective Oncology Therapeutics

Therapeutic Pipeline

Program Indication Discovery Pre-clinical IND-Enabling

Scientific Methodology & Review

Transcriptomic landscape

FIG 1: Molecular differences between Tumor / NAT / Healthy tissue

Foundational Discovery: The Field Effect

Precision Selectivity

Target selection logic

FIG 2: Ixgene Proprietary Target Selection Pipeline

Key References:
  • Slaughter et al., "Field cancerization in oral squamous epithelium," 1953.
  • Aran et al., "The landscape of normal-adjacent-to-tumor tissue," Nature Communications, 2017.
  • Thomson et al., "Molecular signatures of the field effect," Science, 1998.

Contact Us

US Headquarters

Address: 63 Great Rd, Suite 107, Maynard, MA 01754, USA

Email: info@ixgene.com | Phone: +1 (774) 288-9100

Research Center (China)

Email: research@ixgene.com | Phone: +86 15061776107